|
Mexate-aq PreservedDrug - Mexate-aq Preserved The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Methotrexate Sodium
Strength -
EQ 25MG BASE/ML
Applicant -
BRISTOL MYERS SQUIBB
New Drug Application (NDA) Number -
089887
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 14, 1989
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bristol Myers Squibb
Mexate-aq Preserved
Methotrexate Sodium Preservative Free Eq 1gm Base/vial Injectable; Injection
Mexate Eq 100mg Base/vial Injectable; Injection Mexate Eq 20mg Base/vial Injectable; Injection Mexate Eq 250mg Base/vial Injectable; Injection Mexate Eq 50mg Base/vial Injectable; Injection Mexate-aq Eq 25mg Base/ml Injectable; Injection Mexate-aq Preserved Eq 25mg Base/ml Injectable; Injection Methotrexate Sodium Eq 50mg Base/vial Injectable; Injection Methotrexate Sodium Eq 25mg Base/ml Injectable; Injection Methotrexate Sodium Eq 25mg Base/ml Injectable; Injection NewDrugInformation |